Inhibitors of crystallization.
Daudon
M
M
INSERM U90, Département de Néphrologie and Laboratoire de Biochimie A, Hôpital Necker, Paris, France.
Hennequin
C
C
Bader
C
C
Jungers
P
P
Lacour
B
B
Drüecke
T
T
D000818:Animals; D002951:Citrates / Q000494:pharmacology / Q000627:therapeutic use; D019343:Citric Acid; D003460:Crystallization; D004032:Diet; D006023:Glycoproteins / Q000627:therapeutic use; D006025:Glycosaminoglycans / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007669:Kidney Calculi / Q000517:prevention & control*; D008274:Magnesium / Q000494:pharmacology / Q000627:therapeutic use; D009088:Mucoproteins / Q000627:therapeutic use; D058949:Uromodulin
D002951:Citrates; D006023:Glycoproteins; D006025:Glycosaminoglycans; D009088:Mucoproteins; C548612:UMOD protein, human; D058949:Uromodulin; C029490:nephrocalcin; D019343:Citric Acid; D008274:Magnesium